Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ugur Coskun

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Expert Review of Anticancer Therapy|August 23, 2016
Renal cell cancer: overview of the current therapeutic landscapeMustafa Erman, Mustafa Benekli, Mert Basaran, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 3, 2010
Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomasSuleyman Alici, Ugur Coskun, Necati Alkis, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancerEmel Yaman, Aytug Uner, Ozlem Er, et al.
Clinical Breast Cancer|October 21, 2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast CancerSaverio Cinieri, Arlene Chan, Kadri Altundag, et al.
Onkologie|June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatmentEmel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Medical Oncology (Northwood, London, England)|January 25, 2013
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical OncologyErkan Arpaci, Tarkan Yetisyigit, Metin Seker, et al.
Medical Oncology (Northwood, London, England)|December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinomaBanu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
International Immunopharmacology|September 17, 2008
Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectorsDumrul Gulen, Fuminori Abe, Sarah Maas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancerAziz Karaoglu, Ulku Yalcintas Arslan, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Expert Review of Anticancer Therapy|August 23, 2016
Renal cell cancer: overview of the current therapeutic landscapeMustafa Erman, Mustafa Benekli, Mert Basaran, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 3, 2010
Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomasSuleyman Alici, Ugur Coskun, Necati Alkis, et al.
Medical Oncology (Northwood, London, England)|October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancerEmel Yaman, Aytug Uner, Ozlem Er, et al.
Clinical Breast Cancer|October 21, 2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast CancerSaverio Cinieri, Arlene Chan, Kadri Altundag, et al.
Onkologie|June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatmentEmel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Medical Oncology (Northwood, London, England)|January 25, 2013
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical OncologyErkan Arpaci, Tarkan Yetisyigit, Metin Seker, et al.
Medical Oncology (Northwood, London, England)|December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinomaBanu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
International Immunopharmacology|September 17, 2008
Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectorsDumrul Gulen, Fuminori Abe, Sarah Maas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancerAziz Karaoglu, Ulku Yalcintas Arslan, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Pageof 14